SEC Form 4 · accession 0001144204-15-007137
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel F Cain
Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F2,F1 | $8.44 | Feb 5, 2015 | A | 30,000 | A | — | Feb 5, 2025 | Common | 30,000 | 30,000 | D |
Explanation of responses
- F1Option shares shall vest in equal annual installments on the first three year anniversaires of the date of grant.
- F2Received as compensation for service on Board of Directors of issuer.